A Few Senolytic Company Showcase Presentations from the 2020 Online Longevity Leaders Event

The response of governments around the world to the COVID-19 pandemic has essentially shut down the conference circuit for much of 2020. The primary purpose of conferences is networking, and while a number of the conference hosts have organized online events rather than postponing to the end of the year, it just isn't the same. Networking at an online event is a pale shadow of what can be accomplished in the real world. These online conferences do, nonetheless, generate many interesting presentations in the same way as conferences in the real world.

The Longevity Leaders Congress for 2020, the online version of a conference usually held in London, took place at the end of May. In addition to the scheduled discussion panels, a number of companies recorded presentations of their work. These videos are posted to the Longevity Leaders YouTube account. Below I've picked a selection of just the senolytic companies, those focused on the targeted destruction of senescent cells, via quite a diverse set of approaches. There are other companies beyond these, so the full list is worth looking through.

Unity Biotechnology Company Showcase

OneSkin Company Showcase

SIWA Therapeutics Company Showcase

Senolytic Therapeutics Company Showcase

Oisin Biotechnologies Company Showcase

Comments

You nailed it on the networking 🙁 but bravo and THANK YOU for making the best presentations accessible here.

Posted by: August33 at June 10th, 2020 9:47 PM

Thanks for the videos, Reason. Nice find.

I'm really surprised that UNITY frames its work on senolytics in a programmed aging setting (aging has evolutionary knobs that we can dial up and down, like CR, rapamycin and senolytics).

Posted by: Antonio at June 11th, 2020 7:50 AM

One skin looks a bit dodgy from first impressions, like a skin cream company that is trying to dress up their product in science.

I really don't understand the US regulatory system. How can a drug that is applied topically to the skin not need any approval, whereas an oral drug needs phase 3 clinical trials that run into the tens of millions of dollars?

Posted by: jimofoz at June 11th, 2020 2:27 PM

@jimofoz
One is supplement /cosmetic product the other is a medical drug. Is a supplement does really work then it has real active chemical ingredient. Some ingredients are highly available and not regulated. It doesn't mean that they are safe, though. But if they have been in wide use they probably are safe enough.

A bit off topic.
It seems that there so called designer drugs (opiates) they are especially designed to avoid schedule classification and prosecution. After a few years the legal definition gets updated and a new drug is designed.

Posted by: Cuberat at June 11th, 2020 6:04 PM

BTW, very impressive the results of Oisin in mice.

Posted by: Antonio at June 12th, 2020 1:44 AM

this is a very good comment:

"I'm really surprised that UNITY frames its work on senolytics in a programmed aging setting (aging has evolutionary knobs that we can dial up and down, like CR, rapamycin and senolytics)."

you are surprised (like sens and their minis), because you don't know what they know and what they found in their research.

Posted by: x at June 12th, 2020 4:34 PM

Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.